...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: I have opportunity to buy some

Cannot understand why DM does not make Zenith shares available to RVX shareholders post-Newco.

 

Koo

Share
New Message
Please login to post a reply